Skip to menu Skip to content Skip to footer

2025

Journal Article

Analogs of cyclic peptide mortiamide‐d from marine fungi have improved membrane permeability and kill drug‐resistant melanoma cells

Bergeron, Catherine, Bérubé, Christopher, Lamb, Henry, Koda, Yasuko, Craik, David J., Henriques, Sónia Troeira, Voyer, Normand and Lawrence, Nicole (2025). Analogs of cyclic peptide mortiamide‐d from marine fungi have improved membrane permeability and kill drug‐resistant melanoma cells. Peptide Science, 117 (1) e24380. doi: 10.1002/pep2.24380

Analogs of cyclic peptide mortiamide‐d from marine fungi have improved membrane permeability and kill drug‐resistant melanoma cells

2025

Journal Article

Synthesis and Investigation of Peptide-Drug Conjugates Comprising Camptothecin and a Human Protein-Derived Cell-Penetrating Peptide

Palombi, Isabella R., White, Andrew M., Koda, Yasuko, Craik, David J., Lawrence, Nicole and Malins, Lara R. (2025). Synthesis and Investigation of Peptide-Drug Conjugates Comprising Camptothecin and a Human Protein-Derived Cell-Penetrating Peptide. Chemical Biology & Drug Design, 105 (1) e70051, 1-10. doi: 10.1111/cbdd.70051

Synthesis and Investigation of Peptide-Drug Conjugates Comprising Camptothecin and a Human Protein-Derived Cell-Penetrating Peptide

2022

Journal Article

Design and synthesis of tranylcypromine-derived LSD1 inhibitors with improved hERG and microsomal stability profiles

Koda, Yasuko, Sato, Shin, Yamamoto, Hirofumi, Niwa, Hideaki, Watanabe, Hisami, Watanabe, Chiduru, Sato, Tomohiro, Nakamura, Kana, Tanaka, Akiko, Shirouzu, Mikako, Honma, Teruki, Fukami, Takehiro, Koyama, Hiroo and Umehara, Takashi (2022). Design and synthesis of tranylcypromine-derived LSD1 inhibitors with improved hERG and microsomal stability profiles. ACS Medicinal Chemistry Letters, 13 (5), 848-854. doi: 10.1021/acsmedchemlett.2c00120

Design and synthesis of tranylcypromine-derived LSD1 inhibitors with improved hERG and microsomal stability profiles

2008

Journal Article

In vitro stability and permeability studies of liposomal delivery systems for a novel lipophilic endomorphin 1 analogue

Koda, Y., Liang, M., Blanchfield, J. T. and Toth, I. (2008). In vitro stability and permeability studies of liposomal delivery systems for a novel lipophilic endomorphin 1 analogue. International Journal of Pharmaceutics, 356 (1-2), 37-43. doi: 10.1016/j.ijpharm.2007.12.036

In vitro stability and permeability studies of liposomal delivery systems for a novel lipophilic endomorphin 1 analogue

2008

Journal Article

Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides

Koda, Y., Del Borgo, M., Wessling, S., Lazarus, L. H., Okada, Y., Toth, I. and Blanchfield, J. T. (2008). Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides. Bioorganic & Medicinal Chemistry, 16 (11), 6286-6296. doi: 10.1016/j.bmc.2008.04.020

Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides

2007

Journal Article

Caco-2 cell permeability and stability of two D-glucopyranuronamide conjugates of thyrotropin-releasing hormone

Wessling, Susanne T., Ross, Benjamin P., Koda, Yasuko, Blanchfield, Joanne T. and Toth, Istvan (2007). Caco-2 cell permeability and stability of two D-glucopyranuronamide conjugates of thyrotropin-releasing hormone. Bioorganic & Medicinal Chemistry, 15 (14), 4946-4950. doi: 10.1016/j.bmc.2007.04.042

Caco-2 cell permeability and stability of two D-glucopyranuronamide conjugates of thyrotropin-releasing hormone

2007

Journal Article

Comparison of the in vitro apparent permeability and stability of opioid mimetic compounds with that of the native peptide

Koda, Y., Shiotani, K., Toth, I., Tsuda, Y., Okada, Y. and Blanchfield, J. (2007). Comparison of the in vitro apparent permeability and stability of opioid mimetic compounds with that of the native peptide. Bioorganic & Medicinal Chemistry Letters, 17 (7), 2043-2046. doi: 10.1016/j.bmcl.2007.01.051

Comparison of the in vitro apparent permeability and stability of opioid mimetic compounds with that of the native peptide

2007

Journal Article

Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase

Kim, I., Nishi, I., Tsai, H., Bradford, T., Koda, Y., Watanabe, T., Morriseau, C., Blanchfield, J., Toth, I. and Hammock, B. (2007). Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase. Bioorganic & Medicinal Chemistry, 15 (1), 312-323. doi: 10.1016/j.bmc.2006.09.057

Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase

2006

Journal Article

Investigation of the route of absorption of lipid and sugar modified leu-enkephalin analogues and their enzymatic stability using the Caco-2 cell monolayer system

Wu, S., Christopher, C., Koda, Y., Blanchfield, J. T. and Toth, I. (2006). Investigation of the route of absorption of lipid and sugar modified leu-enkephalin analogues and their enzymatic stability using the Caco-2 cell monolayer system. Medicinal Chemistry, 2 (2), 203-211. doi: 10.2174/157340606776056205

Investigation of the route of absorption of lipid and sugar modified leu-enkephalin analogues and their enzymatic stability using the Caco-2 cell monolayer system